Smart Medicines: The Future of Targeted Therapeutics
Smart Medicines: The Future of Targeted Therapeutics
This webinar will explore how advances in materials science and chemistry are reshaping the way we deliver and design medicines.
Chaired by Professor Ruth Cameron, Director of the Cambridge Centre for Medical Materials at the Department of Materials Science & Metallurgy, this session brings together three leading Cambridge researchers whose work is driving innovation at the intersection of materials science, chemistry, biology, and medicine:
- Professor Serena Best (Department of Materials Science & Metallurgy)
- Professor Gonçalo Bernardes (Yusuf Hamied Department of Chemistry)
- Professor Melinda Duer (Yusuf Hamied Department of Chemistry)
Alumni will gain insights into how research is creating “smart” medicines that can sense, respond, and adapt within the body to improve treatment outcomes.
Part of The Future of Physical Sciences webinar series, this session will include short talks and a live Q&A with the speakers, featuring questions from the audience.
Reading Material
In advance of the webinar, we invite you to explore a selection of papers and videos provided by our speakers, offering insights into their research:
Biomimetic collagen scaffolds with anisotropic pore architecture - N Davidenko 1, T Gibb, C Schuster, S M Best, J J Campbell, C J Watson, R E Cameron
Immunodiagnostic plasma amino acid residue biomarkers detect cancer early and predict treatment response - Tang, C., Corredeira, P., Casimiro, S. et al.
Breakthrough Blood Test Detects Cancer Early and Forecasts Treatment Success - Yusuf Hamied Department of Chemistry news article with Professor Gonçalo Bernardes
Brain cancer cells can be ‘reprogrammed’ to stop them from spreading - University of Cambridge news article with Professor Melinda Duer
Take a tour of the Duer lab at the Yusuf Hamied Department of Chemistry
Speakers
Professor Ruth Cameron

Ruth Cameron directs the Cambridge Centre for Medical Materials together with Professor Serena Best. Her multidisciplinary research concerns materials that interact therapeutically with the body. Professor Cameron's work has received widespread recognition including the award of an ERC Advanced Grant. She was awarded the UKSB President’s Prize in 2017, the IOM3 Griffith Medal and Prize in 2018, and the IOP Rosalind Franklin Medal and Prize in 2019 for her work in regenerative medicine and pharmaceutical delivery.
Professor Serena Best

Serena Best is Professor of Materials Science and a Fellow of St. John’s College, and directs the Cambridge Centre for Medical Materials together with Professor Ruth Cameron. Her research interests encompass bioactive ceramics, coatings, composites and scaffolds for skeletal- and soft tissue repair and regeneration. She is a Fellow of the Royal Academy of Engineering (FREng), a Fellow of the Societies Associated with Biomaterials Science and Engineering (FBSE) also a Fellow of the Institute of Materials, Minerals and Mining (FIMMM).
Professor Gonçalo Bernardes

Gonçalo Bernardes is a Professor of Chemical Biology at the University of Cambridge . After completing his D.Phil. degree in 2008 at the University of Oxford, UK, he then performed postdoctoral work at the Max-Planck Institute of Colloids and Interfaces, the ETH Zürich. He started his independent research career in 2013 at the University of Cambridge as a Royal Society University Research Fellow. In 2018 he was appointed University Lecturer and was promoted to Reader in 2019 and to Full Professor in 2022.
Gonçalo is the recipient of three European Research Council grants; and has won many accolades during his career, including the 2024 Corday-Morgan Prize for Chemistry from the Royal Society of Chemistry. His research group interests focus on the use of chemistry principles to provide new biological insights and derive new targeted therapeutics. Finally, he has co-founded a number of companies that use technologies developed in his lab. He is a first generation high-school and university graduate in his family.
Professor Melinda Duer

Professor Melinda Duer is Professor of Biological and Biomedical Chemistry at the University of Cambridge. She studies the molecular structure of the body’s tissues – especially the extracellular matrix, the scaffold that gives tissues their strength and structure. Using powerful analytical tools such as NMR spectroscopy alongside optical, Raman, and electron microscopy, she can probe tissues at the molecular and nanoscale, uncovering how their structure supports cell function and how it changes in disease. Her work reveals how the extracellular matrix is altered in cancer, degenerative diseases, and ageing, providing new opportunities for therapeutic development in degenerative diseases such as vascular calcification (hardening of the arteries). In 2018, she founded Cambridge Oncology Ltd to develop new cancer therapies. Her pioneering work has earned major scientific honours, including the Royal Society of Chemistry’s Interdisciplinary Prize, the Suffrage Science Award, and the Franco-British Prize from the Société Chimique de France. Melinda is also an active science communicator, sharing her enthusiasm for discovery through radio, television, and public talks.
Booking information
Contact
Are you receiving the latest news from your department?
Update your contact details to ensure you receive the latest news, events, and updates from your department.
